Navigation Links
First Cognitive Training to Demonstrate Immediate Generalizability Through Standardized Assessments of Memory
Date:11/19/2007

SAN FRANCISCO, Nov. 19 /PRNewswire/ -- Preliminary data from the IMPACT study are being presented today at the Gerontological Society of America's annual conference. The purpose of the IMPACT ("Improvement in Memory with Plasticity-based Adaptive Cognitive Training") study was to evaluate whether improvements from cognitive training can extend to untrained measures of memory performance and to self-perceived everyday cognition.

The IMPACT trial compares the benefits of a plasticity-based cognitive training program (the Posit Science Brain Fitness Program) to a computer-based learning control matched for computer usage and training intensity. It was chosen to represent current clinical recommendations regarding "staying cognitively active." The IMPACT study is the first large-scale randomized controlled trial of a non-invasive, computer-based cognitive intervention for aging adults that is available for widespread, individual use. In addition to using standardized neuropsychological tests to assess training-related changes in memory, the IMPACT study measured the improvements in cognitive abilities directly reported by study participants themselves.

Using an intensive series of adaptive computerized exercises, the Brain Fitness Program is designed to target the speed and accuracy of auditory and language processes, and neuromodulatory systems associated with learning and memory. Predefined endpoints distinct in design and content from training exercises included standardized neuropsychological assessments of memory and participant-reported outcome (PRO) assessments measuring perceptions of everyday cognition.

After 10 weeks of training, significant group by time interactions favoring the experimental group (the Brain Fitness Program) were seen on the primary endpoint measure (RBANS Auditory Memory) and multiple within-modality but not cross-modality secondary endpoint measures. PRO measures of everyday cognitive function were significant on p
'/>"/>

SOURCE Posit Science Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
... boy from Indonesia had a tumor measuring about 7....or made up around 10% of his body weight.// The tu...ingapore at Mount Elizabeth Hospital involving dif...eloped due to an Iodine deficiency which is an end...
... Brian Jago, from the UK has said that he is being...lable in Wales and Scotland.// Jago has been diagn...n July 2003. He has undergone a stem cell transpla...iled to check the disease. The Southampton Univer...
...nges the one accepted truism of dietary research s...inst colorectal cancer.// The latest analysis of ...od with high fibre content such as cereals, vegeta...to get colon cancer, fiber-cancer association is w...
... the progression of chronic myelogenous leukemia (...ientists. They have also found out that an extract...is called forskolin can be used for suppressing th...e are expected to develop CML this year, and the f...
Other Medicine News:Health News:Study finds no link between fibre and cancer risk 2
(Date:8/25/2008)...lls Found in Menstrual Blood May Offer Long-Lastin...ed Women, OLDSMAR, Fla., Aug. 25 /- ...ould agree that there never seems to be enough,of ... doing something just,for herself usually pales in...s reality has led many women in need of quality ti...
(Date:8/25/2008)...s., Aug. 25 /- Joseph F. Finn, Jr.,C..., Inc. ("Spherics") for,the benefit of creditors, ...al property will be sold at a sealed bid auction o...se formulation of Levodopa-Carbidopa that,is the c...ease, with global,sales estimated at approximately...
(Date:8/25/2008)...ug. 25 /- Anthera Pharmaceuticals,Inc...loping,anti-inflammatory drugs, today announced th... coronary events with Near-term Cardiovascular,Inf...examine the impact of,varespladib when administere... Syndrome (ACS) event., The FRANCIS trial is desi...
(Date:8/22/2008)... in Trial Sponsored by Medical Research Council, ...- Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) a...tocol MDP 301, a Phase III clinical trial of PRO 2...or the prevention of HIV and other,sexually transm...ited,Kingdom,s Medical Research Council (MRC) and ...
Breaking Medicine Technology:Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index 842 1Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index 842 2Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index 842 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference 28ECCO 29 395 1Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference 28ECCO 29 395 2Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference 28ECCO 29 395 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference 28ECCO 29 395 4Heart Attack Survivors Benefit From Rehab 2063 1Heart Attack Survivors Benefit From Rehab 2063 2Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage 568 1Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage 568 2
...romise of Anacor,s,Boron-Based Chemistry in Develo...07 /PRNewswire/ -- Anacor,Pharmaceuticals, a priva...that the journal Science will publish results of r...d clinical candidate,kills fungal cells by interf...d for fungal growth. This unique mechanism of,acti...
...nership with,Illumina , BEYOND GENOME CONFERENCE, ...ading developer of lab and data management,softwar...unced that,it has penned an agreement with Illumin...pant in IlluminaConnect, a,bioinformatics software...ntegration and analysis among the life science com...
Other Medicine Technology:Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,AN2690; Findings Published in Science 2Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,AN2690; Findings Published in Science 3GenoLogics Announces Bioinformatics Partnership with Illumina 2GenoLogics Announces Bioinformatics Partnership with Illumina 3
...ons about insulin dosages and other medication, ab...ed by data from blood glucose tests and other rele...seen by you and your Health Care Providers when th...mats. The FreeStyle CoPilot System makes the data ...
... Photocoagulator.,Retinal physicians throughout ...is multi-color photocoagulators.,For the retinal...integrates green, yellow, and red solid-state,d...hat supports your treatment of a diverse range of ...
... Photocoagulator.,Retinal physicians throughout ...is multi-color photocoagulators.,For the retinal...integrates green, yellow, and red solid-state,d...hat supports your treatment of a diverse range of ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction.
Medicine Products: